New egg-free flu vaccine called promising for those with egg allergy

SAN DIEGO, April 2 - Austrian researchers have developed a unique flu vaccine that is made without egg proteins, which can trigger rare but potentially fatal allergic reactions in some people. "The development represents the newest and most successful approach to influenza vaccine development in 50 years," says Otfried Kistner, Ph.D.

Kistner, a virologist with Baxter Hyland Immuno in Orth/Donau, Austria, and director of the research project, described the vaccine today at the 221st national meeting of the American Chemical Society, the world's largest scientific society.

Although at least two other manufacturers are testing egg-free flu vaccines, Kistner notes that only his company is using cells that have previously been accepted by regulatory authorities in the United States and Europe for human vaccine production.

According to the Austrian scientists, their new manufacturing technique is faster than methods that require chicken eggs, which can be in short supply during a large outbreak. As a result, the technique is expected to lessen the likelihood of flu vaccine shortages like those in the United States last year.

Phase I, II and III clinical trials were done in the United Kingdom, Austria and Poland with more than 2,500 volunteers. They were divided into two age groups: 18-59, and 60 and above. The studies showed that the new vaccine was effective in inducing specific antibodies against influenza, an indication that the vaccine will protect against infection.

"This does not mean that (conventional) vaccines are bad," says Kistner. "The benefit of vaccination is much greater than the risk of allergic reaction. The point of our vaccine is to improve it and minimize the risks which may appear."

Among the older patients who received the new vaccine, significantly fewer adverse effects were observed compared to those who received conventional vaccines. In the younger group, no significant differ

Contact: Charmayne Marsh
American Chemical Society

Page: 1 2 3

Related biology news :

1. Cancer vaccine based on pathogenic listeria bacteria shows promise targeting metastases
2. Pneumococcal vaccine reduces ear infections, pneumonia, new study shows
3. UC Irvine scientists to develop vaccine to combat bioterrorism threat from deadly bacteria
4. First clinical study of new pediatric croup vaccine shows safety, tolerability in adults
5. Protective gene may enhance vaccine responses
6. Protein vaccine fully protects mice from lethal aerosol challenge with ricin toxin
7. New glycan arrays discover autoimmunogenic activities of SARS-CoV: concern over monkey vaccine
8. Growing new breed of vaccine-producing plants to fight human diseases worldwide
9. Childrens Hospital Boston receives more than $10 million to help make smallpox vaccine safer
10. Triple-vaccine strategy stimulates strong HIV-specific immune response in monkeys
11. Herpes tool allows researchers to customize Alzheimers vaccine

Post Your Comments:
TAG: New egg free flu vaccine called promising for those with egg allergy

(Date:10/2/2015)... DUBLIN , Oct. 02 2015 ... addition of the "Enforcing the Law Using ... http://www.researchandmarkets.com/research/6kp5mx/enforcing_the_law ) has announced the addition of ... report to their offering. --> Research ... addition of the "Enforcing the Law Using ...
(Date:9/30/2015)... global glucose monitoring device and diabetes management market is valued ... on the industry from Kalorama Information. Sales in the traditional glucose ... continuous glucose monitoring and sensor segment, according to the healthcare ... in its latest report, The Global Glucose Monitoring Market ... , ...
(Date:9/28/2015)...  The monitoring of vital signs, such as ... an essential component of patient assessment. Changes in ... a patient,s condition. However, in general care areas ... during routine observation rounds only once every four ... these observation rounds, the warning signs can go ...
Breaking Biology News(10 mins):
(Date:10/9/2015)... HERSHEY, Pa. and ROCKVILLE, ... Therapeutics, Inc. ("ITI"), a privately-held biotechnology company developing ... today announced that it has entered into an ... on LAMP-vax products for the treatment or prevention ... Upon execution of the agreement, Immunomic Therapeutics will ...
(Date:10/9/2015)... ... October 09, 2015 , ... Leading microbial genomics startup uBiome ... better understand the relationship between weight management and the microbiome. The study uses the ... participants using an iPhone app. , The uBiome app is available as a free ...
(Date:10/8/2015)... N.J. , Oct. 8, 2015  Genetic testing ... may aid the identification of more couples at risk ... a study presented today at the 2015 American Society ... October 10 in Baltimore, Maryland . ... Quest Diagnostics (NYSE: DGX ) are presenting at ...
(Date:10/8/2015)... , October 8, 2015 ... .   --> Goldman Small Cap ... the small cap and microcap sectors, announced today ... report on PharmaCyte Biotech, Inc. (OTCQB - PMCB), ... on developing and preparing treatments for cancer and ...
Breaking Biology Technology:
Cached News: